The Latest Breaking News from Pfizer

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes awarded since 2000, hosts seven of The Times Higher Education Top 10 science universities, and incubates firms such as Alphabet (Google), Meta and Pfizer that turn federally funded discoveries into billion-dollar…

Stifel Financial downgraded Zoetis stock on Wednesday, causing the animal health company’s shares to fall 4% on the news. The analyst downgrade created a possible long straddle for options investors. The question is whether it’s the best strategy.

Pfizer has underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

With BioNTech sealing a blockbuster $11 billion cancer deal with Bristol-Myers Squibb, should investors be loading up on this rising biotech star?

Frustration and anger mount as Trump administration contemplates new trials and restrictions for Covid vaccines

An EU–UK summit took place in London this week marking a significant step in post-Brexit relations.

Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments.